Skip to main content
SpringerLink
Log in

Dermatomyositis and Drugs

  • Chapter
Rheumaderm

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 455))

Abstract

Dermatomyositis (DM) is an idiopathic inflammatory disorder consisting of skin and skeletal muscle involvement. Patients with skeletal muscle involvement have polymyositis (PM), and those unresponsive to therapy and with characteristic findings on muscle biopsy have inclusion body myositis. Patients without muscle damage and typical skin lesions have amyopathic dermatomyositis. Disease in children (juvenile dermatomyositis) is not associated with malignancy as it may be in adults (paraneoplastic dermatomyositis). Overlap syndrome (OS) is mixed connective tissue disease combining some features of DM, SS and LES. Scleromyositis is overlap syndrome associated with anti-PM-Scl antibodies. Patients with PM, DM or OS with “interstitial lung disease” and anti-synthetase antibodies have an “anti-synthetase syndrome”. Various drugs, including d-penicillamine, NSAIDs, anti-infectious agents, as well as lipid lowering drugs, the HMG-CoA reductase inhibitors may cause myopathy and skin lesions (drug induced dermatomyositis). “Dermatomyositis” occurring as adverse reactions of drugs are rare, irregular and impossible to predict in individual patients. They are very interesting in that they may be keys for explaining the pathogenic mechanisms of the disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Bohan A, Peter, J.B. Polymyositis and dermatomyositis. N. Engl. J. Med. 292, 345–7 (1975).

    Google Scholar 

  2. Euwer R., Sontheimer, R. Amyopathic dermatomyositis: a review. J. Invest. Dermatol. 100, 124S–128S (1993).

    Article  PubMed  CAS  Google Scholar 

  3. Dalakas M.C. Polymyositis, dermatomyositis and inclusion-body myositis. N. Engl. J. Med. 325: 1487–98 (1991).

    Article  PubMed  CAS  Google Scholar 

  4. Ponge A., Mussini J.M., Ponge T. et al. Dermatopolymyosiyis paraneoplasiques. Rev. Med. Int. 8: 251–256 (1987).

    Article  CAS  Google Scholar 

  5. Jablonska S., Blazczyk M., Chorzelski T., Jarzabek-Chorzelska M. Connective tissue disease (CTD) overlap syndromas. Int. Meet. Clin. Dermatol., Athens, 28–31 March. Absreact, 64–65 (1996).

    Google Scholar 

  6. Targoff I.N. Humoral Immunity in Polymyositis/Dermatomyositis. J. Invest. Dermatol. 100: 116S–123S (1993).

    Article  PubMed  CAS  Google Scholar 

  7. Mackie B. Dermatomyositis induced by drugs. Austr. J. Dermatol. 8: 249–251 (1966).

    CAS  Google Scholar 

  8. Fayolle J., Vallon C, Claudy A et al. Dermatomyositis induite par l’isoniazide. Lyon Med. 223: 135–138 (1975).

    Google Scholar 

  9. Fernandes I., Swinson D.R., Hamilton E. Dermatomyositis complicating penicillamine treatment. Ann. Rheum. Dis. 36: 94–5(1977).

    Article  PubMed  CAS  Google Scholar 

  10. Cotterill J.A., Shapiro H. Dermatomyositis after immunisation. Lancet ii: 1158–1159 (1978).

    Article  Google Scholar 

  11. Simpson N.B., Golding J.R. Dermatomyositis induced by penicillamine. Acta Derm. Venereol., (Stockh) 59: 543–4(1979).

    PubMed  CAS  Google Scholar 

  12. Mackie B.S., Mackie L.E. Lupus erythematosus; dermatomyositis induced by sulphacetamide eye drops. Clin. Exp. Dermatol. 4: 111–113 (1979).

    Article  PubMed  CAS  Google Scholar 

  13. Lund H.I., Nielsen M. Penicillamine-induced dermatomyositis. Scand. J. Rheumatol., 12: 350–2 (1983).

    Article  PubMed  CAS  Google Scholar 

  14. Car J., Lorette G., Jacob C. Dermatomyosite induite par la d-penicillamine. Sem. Hop. 63: 399–403 (1987).

    Google Scholar 

  15. Kolsi R., Bahloul Z., Hachicha J., et al. Dermatomyosite induite par la d-penicillamine au cours d’une polyarthrite rheumatoide. A propose d’un cas avec revue de la literature. Rev. Rheum. Mal. Osteo. Articulaires. 59: 341–44(1992).

    Google Scholar 

  16. Jani RM., Gray J.P., Lanham J. Influenza vaccine and dermatomyositis. Vaccine 12/15: 1484 (1994).

    Article  PubMed  CAS  Google Scholar 

  17. Chapurlat R., Tebib J.G., Noel E., et al. Dermatomyosite induite par la d-penicillamine au cours d’une polyarthrite rheumatoide. Rhumatologie. 47: 203–207 (1995).

    Google Scholar 

  18. Umeda Y., Mizutani H., Shimizu M. A case of dermatomyositis with aspiration pneumonia induced by contrast media. Nishinihon J. Dermatol. 57: 454–57 (1995).

    Article  Google Scholar 

  19. Harkcom T.H., Conn D.L. Holley K.E. D-Penicillamine and lupus erythematosus-like syndrome. Ann. Intern. Med. 89: 1012 (1978).

    PubMed  CAS  Google Scholar 

  20. Grob J.J., Collet A.M., Bonerandi J.J. Dermatomyositis-like syndrome induced by nesteroid anti-inflammatory agents. 178: 258–262(1989).

    Google Scholar 

  21. Richard M., Trucheter F., Friedel J. et at. Skin lesions simulating chronic dermatomyositis during longterm hydroxyurea therapy. J. Am. Acad. Dermatol. 21: 797–99 (1989).

    Article  PubMed  CAS  Google Scholar 

  22. K. Zurcher, A.Kreps Dermatomyositis-Like Syndrome (*Polymyositis). In: Cutaneous Drug Reactions, Basel, Karger 360 (1992).

    Google Scholar 

  23. Hanissai A.S., Martinez A.J., Labbour J.T. et al. Vasculitis and myositis secondary to rubeola vaccination. Arch. Neurol., 1973, 28: 202–204.

    Article  Google Scholar 

  24. Nishikai M., Funatsu Y., Homa M: Monoclonal gammapathy, penicilamine-induced polymyositis and systemic sclerosis. Arch. Dermatol., 1974, 110: 253–255.

    Article  PubMed  CAS  Google Scholar 

  25. Cucher B.G., Goldman A.I. D-Penicillamine induced polymyositis in rheumatoid arthritis. Ann. Intern. Med. 85: 615–6(1976).

    PubMed  CAS  Google Scholar 

  26. Tomlinson I.W., Rosenthal F.D. Proximal myopathy after perhexileme maleate treatment. Br. Med. J. i, 1319–1320 (1977).

    Article  Google Scholar 

  27. Schlumpf U., Bussman H.U., Jerusalem F. Myositis bei chronischer Polyarthritis unter d-Penicillamin, medicmentos induziert? Schweiz. Med. Wochenschr. 111: 29–35 (1981).

    PubMed  CAS  Google Scholar 

  28. Doyle DR., McCurley T.I., Sergent J.S. Fatal polymyositis in d-penicillamine-treated rheumatoid arthritis. Ann. Intern. Med. 98: 327–30(1983).

    PubMed  CAS  Google Scholar 

  29. Paradisi M., Parisi I., Valente G. et al. Le polimiositi iatrogene. ImpegoOsp. Sez. Sci. 10/4: 39–40 (1989).

    Google Scholar 

  30. Bessen L.J., Green J.B., Louie E. et al. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N. Engl. J. Med. 318: 708 (1988).

    PubMed  CAS  Google Scholar 

  31. Fusella J., Strosberg J.M. Polymyositis exacerbed by gemfibrocil. J. Rheumatol. 17: 572 (1990).

    PubMed  CAS  Google Scholar 

  32. Sauvage F., Piette J.C., Herson S. et al. Fenofibrate-induced polymyositis. Rev. Med. Interne. 12: 52–54 (1991).

    Article  Google Scholar 

  33. Hodak E., Gadoth N., David M. et al. Muscule damage induced by isotretionin. Br. Med. J. 293: 425–6 (1986).

    Article  CAS  Google Scholar 

  34. Hodak E., David M., Gadoth N., et al. Etretinate induced muscule damage. Br. J. Dermatol. 116: 623–6 (1987).

    Article  PubMed  CAS  Google Scholar 

  35. Ross N.S. et al. Ibuprofen induced myopathy. JAMA 257: 1258 (1987).

    Google Scholar 

  36. Foon K.A. et al. Myalgia from interferon alpha. N. Engl. J. Med. 19, 1259 (1984).

    Google Scholar 

  37. Cronkright P.J. et al. Isoniazid and myopathy. Ann. Intern. Med. 110: 945 (1989).

    PubMed  CAS  Google Scholar 

  38. Gaty B.Z. et al. Ketoconazol and myopathy. Am. J. Dis. Child. 145: 970 (1991).

    Google Scholar 

  39. Kogan A.D. et al. Lovastatin and myopathy. Postgr. Med. 66: 294. (1990).

    Article  CAS  Google Scholar 

  40. Vaher V.M.G. et al. Lovastatin and myopathy. Lancet 2, 1098 (1989).

    Google Scholar 

  41. Engel J.N. et al. Dipheylhydantoin and myopathia. Am. J. Med. 81: 928 (1986).

    Article  PubMed  CAS  Google Scholar 

  42. Harney J. et al. Dipheylhydantoin and myopathia. Neurology 33: 790 (1983).

    Article  PubMed  CAS  Google Scholar 

  43. Jacyk WK. Elevated CPK associated with the use of etretinate. J. Am. Acad. Dermatol. 15: 710 (1984).

    Article  Google Scholar 

  44. McBurney EL, Rosen DA. Elevated creatin phosphokinase with isotretionin. J. Am. Acad. Dermatol. 10: 528–9(1983).

    Article  Google Scholar 

  45. Chen D., Rodsky HE. Elevated CPK and isotretionin. J. Am. Acad. Dermatol. 12: 582–83 (1985).

    Article  Google Scholar 

  46. Shelley W.B. Birch pollen and aspirin psoriasis. JAMA 189: 986–988 (1964).

    Google Scholar 

  47. Shelley W.B. Futher expereriences with an indirect basophil test. Arch. Dermatol. 91: 165–170 (1965).

    Article  Google Scholar 

  48. Espana A., Serna M.J. Etiopatogenia de la dermatomyositis. Monogr. Dermatol. 6/3: 166–172 (1993).

    Google Scholar 

  49. Parker C.W. Drug allergy. N. Engl. J. Med. 292; 511; 732; 957 (1975).

    Article  PubMed  CAS  Google Scholar 

  50. Bessen L.J., Green J.B., Louie E. et al. Severe polymyositis-like syndrome associated with zidovudine therapy of AIDS and ARC. N. Engl. J. Med. 318: 708. (1988)

    PubMed  CAS  Google Scholar 

  51. Dalakas M.C., Illa I., Pezeshkpour G.H., et al. Mitochondrial myopathy caused by long-term zidovudine therapy. N. Engl. J. Med. 322: 1098–1105 (1990).

    Article  PubMed  CAS  Google Scholar 

  52. Arnaudo E., Dalakas M.C., Shanske S., et al. Depletion of muscle mitochondrial DNA in AIDS patients with zudovudine-induced myopathy. Lancet 337: 508–510 (1991).

    Article  PubMed  CAS  Google Scholar 

  53. Fusella J., Strosberg J.M. Polymyositis exacerbed by gemfibrocil. J. Rheumatol., 17: 572 (1990).

    PubMed  CAS  Google Scholar 

  54. Sauvage F., Piette J.C., Herson S. et al. Fenofibrate-induced polymyositis. Rev. Med.Interne 12: 52–54 (1991).

    Article  Google Scholar 

  55. Schalke B.B., Schmidt B., Toyka K. et al. Pravastatin and dermaromyositis. N. Engl. J. Med. 327: 649 (1992).

    PubMed  CAS  Google Scholar 

  56. Khattak F.H., Morris I.M., Branford W.A. Simvastatin-associated dermatomyositis. Br. J. Rheumatol. 33: 199 (1994).

    Article  PubMed  CAS  Google Scholar 

  57. Norman D.J., Iillingworth D.R., Munson J. et al. Myositis and acute renal failure in a heart transplantant recipient receiving lovastatin. N. Engl. J. Med. 318: 46–47 (1988).

    Article  PubMed  CAS  Google Scholar 

  58. Bilheimer D.W. Myopathy from simvastatin. Cardiology, 77, Suppl, 4: 58 (1990).

    Article  PubMed  Google Scholar 

  59. Deslypere J.P. et al. Myopathy from simvastatin. Ann. Intern. Med, 114: 342 (1991).

    PubMed  CAS  Google Scholar 

  60. al-Jubouri M.A. Briston P.G., Sinclair D. et al. Myxoedema revealed by simvastatin indiced myopathy. BMJ., 308: 588 (1994)

    Article  PubMed  CAS  Google Scholar 

  61. Monk B.E., Pembroke A.C. Dermatomyositis following radiotherapy. Br. J. Dermatol., (suppl. 24): 103 (1983).

    Article  Google Scholar 

  62. Harris A.L., Smith I.E., Snaith M. Tamoxifen-induced tumor regression associated with dermatomyositis. Br. Med. 1, 284: 1674–5 (1982).

    Article  Google Scholar 

  63. Litt J.Z., Pawlak W.A. Drug Eruption Reference Manual, Parthen. Publ. Group, 344–6 (1997).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Medicine, Sofia, Bulgaria

    Prof. Assen L. Dourmishev (Prof.) & L. A. Dourmishev

Authors
  1. Prof. Assen L. Dourmishev
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. L. A. Dourmishev
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. St. Luke’s Hospital, University of Malta Medical School, Malta, USA

    Carmel Mallia

  2. Jefferson Medical College, Thomas Jefferson Universit, Philadelphia, Pennsylvania, USA

    Jouni Uitto

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dourmishev, A.L., Dourmishev, L.A. (1999). Dermatomyositis and Drugs. In: Mallia, C., Uitto, J. (eds) Rheumaderm. Advances in Experimental Medicine and Biology, vol 455. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-4857-7_27

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-4857-7_27

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-7203-5

  • Online ISBN: 978-1-4615-4857-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation